Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in Microsoft Word file format.
  • Where available, full URLs/ full DOI/ online links for each reference should be provided.
  • The text should be in 1.5 line spaced, uses a 12-point font in Times New Roman and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines. Full names of all authors have to be correctly typed along with individual authors details (Department, Institution, etc) including emails has to be correctly entered in the online system during submission.
  • If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Author Guidelines

Author Guidelines 

Journal of Bharatpur Hospital (JoBH) is a peer reviewed Bio-medical journal that is published semiannually and follows a peer-reviewed, open-access format. The journal focuses on all areas of biomedical sciences. Its primary goal is to serve as a robust platform for researchers from Nepal and other countries, particularly in the field of Biomedical Sciences.

This journal will publish the articles of the following categories

  • Original articles
  • Systematic Reviews/Meta-analyses
  • Review articles
  • Case Report/ Series
  • Images in clinical sciences
  • Short communications
  • Editorials
  • Viewpoints
  • Book Reviews
  • Medical Education
  • Specially Invited Articles
  • Letters to the Editor
  • Focus and Scope

Types of Manuscripts

  • Editorial Articles: These articles are written in each issue by the Editor-in-Chief or members of the editorial board or any experts invited by the Editor-in-Chief. It is unstructured and has no word or reference limitations.
  • Original Articles: Randomized clinical trials, interventional studies, studies of screening and diagnostic tests, outcome studies, cost-effectiveness analyses, Observational studies (Descriptive and analytical) will be considered for publication. Articles can be up to 3000 words excluding the abstract (up to 250 words), with 5 tables and/or figures, and up to 30 references.
  • Review Articles: Systematic critical reviews of literature and data sources will be accepted. Reviews must not exceed 4000 words, excluding the abstract (can be up to 250 words), figures, tables, and references (up to 100).
  • Medical education: Articles pertinent to the education process in the medical field will be published in this section. It may be about the teaching-learning process at undergraduate, postgraduate or higher levels. The word limit can be up to 3000 excluding the unstructured abstract (up to 250 words), with 5 tables and/or figures, and up to 30 references.
  • Case Reports: Interesting or new or rare cases with clinical significance or implications along with a literature review can be reported. Such case reports can be up to 1000 words, excluding abstract (can be up to 100 words), references (can be up to 15), and photographs (up to 5). 
  • Viewpoint: Articles related to your own point of view or personal views on any issues related to health will be published. The viewpoint can be up to 1000 words excluding references (up to 10).
  • Letter to the Editor: Letters concerning the articles published in JoBH can be up to 500 words, excluding references (up to 5) and must be received within one month after the publication of the article. The author must give a full reference to the article published in JoBH while writing the letter to which he is referring.

AUTHORSHIP
Authorship credit should be limited to those who have made a significant contribution to the conception, design, execution, analysis, interpretation of the study, drafting of the article, or revising it critically for intellectual content following ICMJE guidelines (https://www.icmje.org/

DECLARATION
A declaration should be submitted stating that the manuscript represents valid and original work, has not been submitted simultaneously to another journal, has not been accepted for publication elsewhere and has not already been published. This is maintained during the start of the online submission process.

Originality and plagiarism: The authors should ensure that they have developed entirely original works. They have to use the contents of works, part of work, and words or statements of others, that has been cited or quoted appropriately.

Acknowledgment of sources: Acknowledgment of other people’s work must always be provided.

Reporting standards: Results of the original research work of authors should provide an accurate account of the work with a clear discussion of its implications.

Conflicts of interest: The authors must disclose a potential conflict of interest for all submissions and relationships with others.

Financial disclosure: The authors must disclose financial support or not on this research.

Data access and retention: Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be agreed to provide public access to such data if the editorial board finds something doubtful. So, research must follow ethical principal of scientific investigation.

Critical errors in published works: If an author finds a critical error or inaccuracy in his/her own published work, it is the author's responsibility to promptly notify the journal editor and cooperate with the editor to retract or correct the paper.

Checklist for Online Submission of JoBH
The Journal of Bharatpur Hospital (JoBH) welcomes the author(s) for publication of all areas of biomedical sciences as mention above. The JoBH editorial staff would like to thank for all author(s) for their submissions in JoBH.

It means a lot to us, and we carefully and thoughtfully evaluate each one as we review it. Unfortunately, there are a lot of applications waiting to be reviewed, but we guarantee to give yours the time and attention it needs when the time comes. After a successful submission, an automatic email will be sent to you.

Dear author(s) as part of the online submission process, authors are required to check off their submission's check list with following documents and submissions may be returned to authors that do not adhere to these guidelines and required documents (please refer to Authors guidelines).

  1. Covering letter addressed to the chief editor by the corresponding author
  2. Declaration signed by all authors mentioning, that it is not yet published or sent for publication. 
  3. Letter of ethical clearance from the relevant authorities is included.
  4. Authorship
  5. Manuscript needs to be prepared as per guideline
  6. Please include ORCID id of all author(s) in the online submission along with affiliation.
  7. Details of correspondence (Full name, Department, Full name and place of working institution, Phone number, Emai Id)
  8. For co-authors (Full name, Department, Full name and place of working institution, Emai Id)
  9. Full DOI/PubMed/PMID/Google Scholar or link of all references must be provided.

The manuscripts should be submitted online using the online submission process. Authors need to register with the journal prior to submitting, or if already registered can simply log in and begin the 5-step process. Please include ORCID id of authors while submission.

Note: Incomplete Submission (required document not submitted, and co-author(s) detail not entered into the system and not provided during submission) or submission not in JoBH formatting will be rejected right away.

Supplementary Files: Please also submit supplementary files along with your manuscript

  1. Forwarding letter
  2. Authorship
  3. Declaration
  4. Manuscript preparation guideline

MANUSCRIPT PREPARATION in accordance with the “Uniform requirement for Manuscripts submitted to Biomedical Journals” developed by the ICMJE. The general guidelines are outlined below.

  • Manuscripts should be written in Times New Roman style with 1.5 line space and justified alignment (Ctrl+J) on one side.
  • Do not use tabs, indents, or extra spaces before the start of a paragraph.
  • Title not more than 50 characters
  • Abstract page contains the full title of the manuscript
  • Abstract provided (not more than 150±15 words for case reports and 250±15 words for original articles)
  • Structured abstract provided for an original article- IMRD (Introduction, Methods, Result, Conclusion)
  • Key words provided arrange them in alphabetical order (Three to six)
  • Pages should be numbered consecutively at the bottom, starting from the title page.
  • Line numbers must be included in the document.
  • Consistency in language is required, with a preference for American English.
  • Abbreviations should not appear in the title and abstract, except for universally recognized terms like AIDS and WHO.
  • Standard abbreviations and symbols from textbooks can be used if the full form is given the first time (e.g., knowledge, attitude, and practices (KAP)).
  • Units should be abbreviated when reporting numerical information, with a space between the number and the unit. In non-numerical contexts, use the full term (e.g., mean height was 36.2 cm; length measured in meters).
  • Percentages should be written as "%" with no space between the number and sign. Use two decimal points for populations over 100, one decimal point for populations between 10-100, and avoid percentages for populations under 10.
  • Always use zero (0) before the decimal point in fractions (e.g., 0.235, not .235).
  • Sentences should begin with words, not numbers.
  • When a sentence starts with a number and unit, both should be spelled out (e.g., eighty-four milligrams, not 84 mg).
  • Do not use ‘&’ or ‘@’ in the text.
  • pH should be written as "pH 7.4" without quotation marks.
  • Preferably, drugs should be written using generic names. If using a brand name, it should begin with a capital letter.
  • Do not use automatic referencing, footnotes, headers, footers, etc., in the software.
  • Avoid using ‘O’ for zero (0) and ‘l’ for one (1).

Units of Measurement:

  • Use metric units (meter, kilogram, or liter) or decimal multiples for length, height, weight, and volume.
  • Temperatures should be reported in degrees Celsius, and blood pressure in millimeters of mercury (mmHg).
  • Report laboratory data in both local and International System of Units (SI), with non-SI alternatives in parentheses if necessary.
  • Drug concentrations can be reported in either SI or mass units, with the alternative in parentheses when appropriate.
  • Currency exchange rates should be in US dollars along with the local currency for the relevant date.

Tables and figures

  • No repetition of data in tables/graphs and in text
  • Actual numbers from which graphs drawn, provided
  • Figures necessary and of good quality (colour)
  • Table and figure numbers in Arabic letters (not Roman)
  • Labels pasted on back of the photographs (no names written)
  • Figure legends provided (not more than 40 words)
  • Patients’ privacy maintained (if not, written permission enclosed)
  • Credit notes for borrowed figures/tables provided.

Reporting Time and Dates

  • Use a 12-hour time system with four digits, the first two for hours and the last two for minutes (e.g., 09:30 AM).
  • Dates should be written as Month Day, Year, separated by a comma (e.g., October 4, 2019).

Revised Manuscripts

  • Submit the revised manuscript in two versions: one with track changes and one without.
  • Provide a detailed point-by-point response to the reviewer/editor comments, specifying the changes made and their locations (e.g., Methods section, line 12, page 5).
  • If disagreeing with any comments, provide a thorough rebuttal explaining and justifying your decision.

TITLE PAGE
The title page should be submitted as a separate file and must include the following:

  • Type of Manuscript: Clearly mention your research is original article or Review article or Case report, etc.
  • Title of the Article: The title should be in bold. The first letter of the first word should be capitalized, and all other words should be in lowercase, except for proper nouns. It should be clear, concise, and accurately represent the content of the research paper. Descriptive titles are preferred over declarative or interrogative ones.
  • Short Running Title: This should not exceed 45 characters.
  • Authors: List all relevant authors in sequential order, including their full names, departments, institutions, and addresses, email address. The corresponding author should be identified with their full name, department(s), institution(s), country, postal address, email, and telephone/mobile number. The corresponding author must ensure that all co-authors are correctly listed, have reviewed and approved the final manuscript, and agree to its submission for publication.
  • ORCID iD: ORCID iD for all authors need to be provide. If you do not have an ORCID iD, you can register at ORCID for free.
  • Word Counts: Provide the total word count for the manuscript, excluding the abstract, acknowledgments, tables, figures, and references. Include the total word count for the abstract (excluding keywords).
  • Figures/Tables: State the total number of figures and/or tables (maximum of 5).
  • References: State the total number of references (minimum is 15 and maximum 30). Provide the latest articles references. Full DOI/PubMed/PMID/Google Scholar or link of all references must be provided.
  • Page Count: Provide the total number of pages.

ABSTRACT
The abstract should capture the essence of the entire paper, maintaining clarity and conciseness while omitting cited references and unnecessary details. It must not exceed 250 words and must follow the prescribed format: Introduction, Methods, Results, Conclusions, and Keywords (for original articles). For case reports or other article types, a structured format is not required, and the abstract should be limited to 100 words. It is essential to avoid using abbreviations, footnotes, or references in the abstract. Keywords should be provided in a list of three to six terms, arranged alphabetically and separated by commas, with the first letter of the first keyword capitalized and all others in lowercase. Using Medical Subject Headings (MeSH) terms is highly recommended, and the keywords will not count toward the abstract's word limit.

INTRODUCTION
The introduction should provide the background of the study, summarizing existing literature and highlighting the necessity of the research and its contribution to the field. It should explain the research gaps and clearly state the study's objectives. The first paragraph should offer a brief overview of existing knowledge in the research area, followed by the second paragraph, which summarizes previous studies, their limitations, and unresolved questions. The third paragraph should outline what the study aims to achieve and why it is important. The objective of the paper should be clearly stated in the concluding sentence of the introduction. The introduction should not exceed 150-200 words and should follow the funnel structure, starting with general background information and narrowing down to the specific research question. Avoid an extensive review of the subject and focus on presenting the rationale and purpose of the study.

METHOD
The Methods section should be started with type of the study (Qualitative, quantitative or mixed) with suitable study design (Randomized Clinical Trials, Cross-sectional Study with retrospective Studies or prospective approach, Cohort Study, Case-control Study, Experimental Studies, Quasi-experimental study, Longitudinal Studies, Surveys, Case Reports, Case Series, Meta-Analysis, Systematic Reviews). It should include the study duration (data collection period), study area and setting, and study population. The sample size and sampling method, along with inclusion and exclusion criteria, should be detailed. Tools and techniques used for data collection and how the outcomes/variables were measured should be described. Additionally, the section should provide technical details on methods, apparatus, and procedures, referencing established protocols and ensuring replicability. Any processes, interventions, and comparisons should be clearly described, including generic and proprietary drug names (with brand names in parentheses if applicable). Potential biases and the measures taken to minimize them should be discussed. Ethical approval from an Institutional Review Committee, including the approval number, must be mentioned, along with a statement of written informed consent from participants (or their guardians) for using identifiable information. Finally, the statistical analysis methods and software used should be provided.

RESULTS
The Results section should present the demographic details of study participants, which can be included in the text or as tables/figures. The main outcomes of the study and the data obtained should be summarized logically in text, tables, and graphs. Results should be presented concisely, avoiding the repetition of data already displayed in tables and figures. Present the results in a logical sequence, highlighting key findings first. Express results as n(%) in the format, for example, 85(22.35%). Tables and figures should be integrated sequentially and referenced appropriately within the text. In this section, include minimum, maximum, and mean values, along with statistical values. Avoid interpreting the results; this will be done in the Discussion section. Confidence intervals (CI) and p-values should be included with significance tests. The exact p-value should be reported, for instance, p<0.001, and p-values greater than 0.01 should be reported to two decimal places, while those between 0.01 and 0.001 should be reported to three decimal places. For clarity, statistical significance should be distinguished from clinical or non-statistical significance, with the term “significant” reserved for statistical significance. Avoid using non-technical terms incorrectly, such as "random" or "normal," as they have specific statistical meanings and should be clarified in the discussion section.

Guidelines for tables
In preparing tables for your manuscript, ensure they are created directly in Word without embedding Excel files or images, and avoid excessive formatting such as merged cells or coloring. Tables should be numbered consecutively with Arabic numerals and include a clear, concise title placed above the table, e.g., "Table 1. Demographic information of the study participants" (without a full stop at the end of the title). Refer to each table in the text by its number, avoiding terms like "the table above" or "the table below." Keep tables within the limit of 8 columns and 20 rows, and avoid duplicating textual material. Explanatory notes should be placed as footnotes, using symbols (*, **, †, ††, etc.) for clarification. Each table should be cited in the text, and the data should be presented logically to ensure clarity, with all footnotes following the symbol sequence for detailed explanations.

Guidelines for figures
Figures in your manuscript should be numbered consecutively in the order they are first cited in the text, with the title placed below the figure, following the format "Figure 1. [Title]" without a full stop at the end. For example, "Figure 1. Prevalence of abuse among medical student." If any figure has been previously published, the original source must be acknowledged, and written permission from the copyright holder must be submitted. Figures should be provided electronically, with a resolution of 300 dpi and dimensions between 640 x 480 to 800 x 600 pixels, in JPEG format. Ensure that letters, numbers, and symbols on figures are clear and legible, even when reduced for publication. Patient details should be removed or blacked out in figures, and if the identity cannot be removed, written consent must be obtained. For photomicrographs, stains and magnification should be specified, and internal scale markers should be included, with symbols, arrows, or letters contrasting with the background for clarity.

DISCUSSION
In the discussion section, begin by elaborating on the findings of your research, providing citations from previous studies that support the hypothesis and the present results. Compare and contrast your findings with relevant studies, highlighting any differences or similarities. Focus on the new and significant aspects of your study, emphasizing what it contributes to the existing body of knowledge. Ensure that the discussion aligns with the study's objectives, tying back to the questions or hypotheses posed earlier. Avoid repeating data or information already presented in the introduction or results sections. Acknowledge and state the limitations of your study, such as sample size, methodology, or any other factors that could have influenced the results. This section should provide a critical and thoughtful interpretation of the findings in the context of existing research.

CONCLUSION
The conclusion should directly reflect the objectives of the study, drawing clear links between the research questions and the findings. It should summarize the key outcomes that are supported by the evidence presented in the results section, highlighting their significance. Emphasize the implications of the findings for future research, suggesting areas where further investigation may be beneficial. Additionally, discuss how the findings could influence clinical practice, providing practical recommendations or potential applications. Avoid general conclusions that do not stem from the results and refrain from citing or discussing other studies in this section. The conclusion should focus solely on the direct outcomes and implications of your study.

ACKNOWLEDGMENT
The acknowledgment section should briefly recognize individuals, institutions, or funding agencies that contributed to the study but do not meet the criteria for authorship. This may include those who provided professional writing services, materials, or other forms of support. Clearly specify the nature of the support provided, whether financial, intellectual, or logistical. While this section is not mandatory, it should be kept concise and focused, acknowledging only those who made significant contributions to the article's development

CONFLICTS OF INTEREST
The "Conflicts of Interest" section should disclose any potential conflicts, such as employment, affiliations, consultancy roles, honoraria, grants, or other funding that could influence the study's results or interpretation. If there are no conflicts of interest, the statement should read: "None declared." This ensures transparency and allows readers to assess the impartiality of the research.

SOURCE OF FUNDING
All sources of funding E.g.: Grants, funds, honoraria sanctioned for research, if any, should be declared. The role of the funding body in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript should be declared. The sentence should begin: "This work was supported by". Proposal numbers should be complete and accurate and provided in parentheses as follows: "(proposal number xxx)". If there is no source of funding, it should be written as: “None”

AUTHOR/S CONTRIBUTION
The authors' contributions should be listed in the order of their involvement, specifying their roles in the research process. For example: HPU designed the research, performed statistical analysis, and prepared the first draft of the manuscript; AK collected data and contributed to the preparation of the first draft; BG, TD, BK explained and interpreted the data and contributed to preparing the manuscript draft. All authors read and approved the final manuscript.

CITATIONS AND REFERENCES

  • Responsibility for the accuracy and completeness of citations and references rests entirely on the author.
  • Citations and references should be prepared following the Vancouver style.

CITATIONS

  • In-text citations should follow a specific format with Arabic numerals in superscript placed immediately after punctuation, without a space. For example: Nepal is beautiful country.3 and not "Nepal is beautiful country" 3.
  • When the author's name is cited in the text, the citation number should be placed immediately after the name. If a work has more than one author, use "et al." after the first author's name, such as "Upadhyay et al.7 stated that...".
  • When citing multiple references, separate them with commas and no spaces, e.g., Prevalenc of disease is very high.16,23,34 For a continuous sequence of references, use a hyphen to separate the first and last number of the sequence, e.g., 5-9. For a non-continuous list of references, separate them with commas and a hyphen when applicable, e.g., 2-8,13,18

REFERENCES

  • References should be listed in numerical order as they are cited in the text, tables, or figures. Use Arabic numerals (1, 2, 3, 4, 5, 6, 7, 8, 9) for the numbering. The reference list should be placed at the end of the manuscript and should be consistent in referencing style throughout the manuscript.
  • Each reference should include the last names and initials of the authors, the title of the article, the name of the publication, the year of publication, volume number, issue, inclusive pages, and DOI (Digital Object Identifier) and/or PMID (PubMed ID), if available. For journal titles, abbreviate them according to the style used in Index Medicus. For non-indexed journals, use the full name of the journal.
  • If a reference has six or fewer authors, list all of them. For seven or more authors, list the first six followed by "et al." There should be no space between the year and the rest of the citation, and only one space should be used between words up to the year. Do not include the month or date when writing the year in a reference (e.g., "2022," not "2022 February 5").
  • References should also include DOI (Digital Object Identifier) and PMID (PubMed ID) when available. Authors can find the DOI for their references using the Crossref Simple Text Query tool (https://apps.crossref.org/SimpleTextQuery).

JOURNAL ARTICLE: PRINT

Article with 1 to 6 authors
Author(s). Title of article. Abbreviated title of the journal. Year; Volume number(Issue number): Page range.

Example:
Smith J, Brown P, Williams R. Effects of climate change on public health in urban areas. Environ Health Perspect. 2020;128(4):400-409.

Article with more than 6 authors
Author(s). Title of article. Abbreviated title of the journal. Year; Volume number(Issue number): Page range.

Example:
Smith J, Brown P, Williams R, Taylor H, Jones M, Davis L, et al. Impact of urbanization on local ecosystems. Urban Ecol. 2022;35(3):150-160.

JOURNAL ARTICLE: ONLINE/ELECTRONIC

Author(s). Title of article. Abbreviated title of the journal [Internet]. Year [cited date]. Available from: URL. DOI: ………… PMID: ……

Example:
Smith J, Brown P, Williams R. The role of public policy in environmental conservation. Environ Policy Rev [Internet]. 2021 [cited 2025 Jan 12]. Available from: https://www.envpolicyreview.com/articles/2021/role-public-policy. DOI: 10.1038/451397a

BOOK: PRINT

Author(s). Title of book. Edition (if applicable). Place of publication: Publisher; Year.

Example:
Smith J, Brown P. Environmental Science: Principles and Practices. 2nd ed. New York: Academic Press; 2020.

BOOK: ONLINE/ELECTRONIC

Author(s). Title of book [Internet]. Edition (if applicable). Place of publication: Publisher; Year [cited date]. Available from: URL.DOI: (if available)

Example:
Smith J, Brown P. Environmental Science: Principles and Practices [Internet]. 2nd ed. New York: Academic Press; 2020 [cited 2025 Jan 12]. Available from:https://www.academicpress.com/environmentalscience

AUTHORSHIP

Date: ...........
To: The Editor-in-Chief
Journal of Bharatpur Hospital (JOBH) 
Bharatpur, Nepal

Subject:  Authorship for article titled “………………..(Title of article)”

Dear Editor,

I/We, the undersigned author (s) of the manuscript entitled: …………………… hereby declare that the above manuscript which is submitted to Journal of Bharatpur Hospital (JOBH)

  1. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
  2. I/We have seen and approved the content of the submitted manuscript.
  3. I/We declare that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
  4. I/We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs.  We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from  @gmail.com
  5. All persons who have made substantial contributions to the work reported in the manuscript, including but not limited to generating data, performing statistical analysis, and/or substantial editing that affects the content of the paper, but whose contribution is not sufficient to warrant inclusion as an author have been maned in the Acknowledgment and have given the Journal permission to be named. If I (we) do not include an acknowledgment, that means I (we) have not received substantial contributions from nonauthors.

I/We also agree to the authorship of the article in the following sequence: -
First Author
Author Name: ........
Email Address: ........
Signature: ................

Second Author ... etc.

The corresponding author(s) should be identified by bold letter and an asterisk *

Indicate the contributions of each author to the following items

  • Concepts
  • Design
  • Literature search
  • Clinical studies
  • Experimental studies
  • Data aquisition
  • Data Compilation
  • Statistical analysis
  • Manuscript preparation
  • Manuscript editing
  • Manuscript review

Sincerely yours,

Name              : …………………………………..(Full name)
Affiliation       : …………………………………..(Organization and post)
Postal Address: ……………………………………..
Phone No        : …………………………………..(Mobile no.)
Email              : ……………………………………

DECLARATION

(This form should be completely signed by all the authors and should be uploaded at the time of submission)

Date: …………………….

I/We, the undersigned author (s) of the manuscript entitled: ............................ hereby declare that the above manuscript which is submitted to Journal of Bharatpur Hospital (JOBH).

Declaration

  1. We confirm that this manuscript represents original work. Neither the whole manuscript nor a part of it, has not been published (not even under consideration elsewhere) or submitted to or accepted for publication in any form, in any other journal or scientific magazine.
  2. We would like to make sure that all the data collected during the study period has been presented in the manuscript and no data from this study will be published separately. If requested by the journal, we will provide all the data/information to the editor and fully cooperate with the journal.
  3. We confirm that all authors listed on the title page have contributed significantly to the work, have read the final version of the manuscript to validate and confirm the content, data and interpretation, responsible for what is mentioned in it, and agree to its submission to the journal.
  4. We confirm that the order/sequence of authors list is correct and been approved by all of us.No modifications and additions are required unless editors receive agreement from all authors with proper explanation.
  5. We confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies.
  6. We have obtained the necessary approvals for the clinical trials, and the corresponding trial registration number and name of the trial register have been included in the manuscript.
  7. The source of funding has been included in the manuscript stating which authors they apply to, listing all the funding agencies and grants details.
  8. We confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
  9. We assure that a copyright permission has been obtained for materials published elsewhere and which require this permission for reproduction and has been acknowledged in the text of the paper.
  10. We assure you to provide the raw file of the data, images when journal asks for.
  11. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. We have also followed the regulations of our institutions concerning intellectual property.
    The undersigned author(s) hereby assigns, conveys, and otherwise transfers all rights, title, interest, and copyright ownership of said work for publication. Work includes the material submitted for publication and any other related material submitted to JOBH. In the event that Journal of Bharatpur Hospital (JOBH).
  12. Does not publish said work, the author(s) will be so notified and all rights assigned hereunder will revert to the author(s). JOBH shall own the work, including (1) copyright; (2) the right to grant permission to republish the article in whole or in part, with or without fee; (3) the right to produce preprints or reprints and translate into languages other than English for sale or free distribution; and (4) the right to republish the work in a collection of articles in any other mechanical or electronic format.
  13. We accept that Editor-in-Chief’s decision over acceptance or rejection of the article for publication.

Authors' names, email addresses and signatures.

FORWARDING LETTER

Date: .........
To: The Editor in Chief
Journal of Bharatpur Hospital (JOBH)
Nepal

Subject:  Submission of manuscript of “Title of the Article”

Dear Editor in Chief,

I’m pleased to submit a/an (Type of manuscript) entitled “[Title of the Article]” for consideration for publication in theJournal of  Bharatpur Hospital (JOBH). In this manuscript, (please explain in your own words the importance or novelty of your study, the problem that is being addressed, why do you think it is suitable for publication and what new things it adds to the existing literature. Do not simply insert your abstract into the cover letter).

This manuscript has not been published and is not under consideration for publication elsewhere.

There are

  • Number of Figures/Images
  • Number of Tables
  • Other related info if any

Following are the documents attached herewith

  • Authorship
  • Declaration
  • Manuscript “Title of the Article”
  • Tables/Figures related to manuscript
  • Ethical approval letter

Above document has been submitted in electronic version to the JOBH. If you have any questions or queries, you can write me at my email or call me at my phone number given below.

Please, acknowledge the received of this article to my email or contact address. Hoping for your kind co-operation in this regard.

Sincerely yours,

Name              : Full Name
Affiliation       : Designation and your affiliation
Postal Address: Complete address for effective communication
Phone No        : Easily available Phone or Mobile no.
Email              : Working, regular Email to reach you quickly

Privacy Statement

Nepal Journals Online (NepJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, NepJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to NepJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 8 May 2025)